Abstract
HPPK (6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase) catalyses the transfer of pyrophosphate from ATP to HMDP (6-hydroxymethyl-7,8-dihydropterin), to form AMP and DHPPP (6-hydroxymethyl-7,8-dihydropterin pyrophosphate). This transformation is a key step in the biosynthesis of folic acid, and HPPK is consequently a target for antimicrobial drugs. The substrates are known to bind to HPPK in an ordered manner, with ATP binding first followed by HMDP. In the present study we show by isothermal titration calorimetry that the product, DHPPP, can bind to the HPPK apoenzyme with high affinity (equilibrium dissociation constant, K(d)=0.2 microM), but without the enhancement of pterin fluorescence that occurs on binding of HMDP. The transient kinetics of the enzyme can be monitored by measuring the change in the fluorescence of the pterin ring using stopped-flow methods. The fluorescence exhibits a pronounced biphasic behaviour: it initially rises and then declines back to its original level. This behaviour is in agreement with a two-state kinetic model, with the first phase of fluorescence increase associated with HMDP binding to the enzyme, and the second phase with a slow event that occurs after the reaction has taken place. The HPPK-DHPPP and HPPK-DHPPP-AMP complexes were examined by NMR, and the binding site for DHPPP partially mapped from changes in chemical shifts identified from two dimensional 1H/15N heteronuclear single-quantum coherence spectra. The results demonstrate that DHPPP, in contrast to HMDP, is able to bind to the HPPK apoenzyme and suggest that the pyrophosphate moieties on the ligand play an important role in establishment of a high affinity binding site for the pterin ring.
Full Text
The Full Text of this article is available as a PDF (523.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bermingham A., Bottomley J. R., Primrose W. U., Derrick J. P. Equilibrium and kinetic studies of substrate binding to 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Escherichia coli. J Biol Chem. 2000 Jun 16;275(24):17962–17967. doi: 10.1074/jbc.M000331200. [DOI] [PubMed] [Google Scholar]
- Bermingham Alun, Derrick Jeremy P. The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery. Bioessays. 2002 Jul;24(7):637–648. doi: 10.1002/bies.10114. [DOI] [PubMed] [Google Scholar]
- Blaszczyk J., Shi G., Yan H., Ji X. Catalytic center assembly of HPPK as revealed by the crystal structure of a ternary complex at 1.25 A resolution. Structure. 2000 Oct 15;8(10):1049–1058. doi: 10.1016/s0969-2126(00)00502-5. [DOI] [PubMed] [Google Scholar]
- Blaszczyk Jaroslaw, Li Yue, Shi Genbin, Yan Honggao, Ji Xinhua. Dynamic roles of arginine residues 82 and 92 of Escherichia coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: crystallographic studies. Biochemistry. 2003 Feb 18;42(6):1573–1580. doi: 10.1021/bi0267994. [DOI] [PubMed] [Google Scholar]
- Hennig M., Dale G. E., D'arcy A., Danel F., Fischer S., Gray C. P., Jolidon S., Müller F., Page M. G., Pattison P. The structure and function of the 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Haemophilus influenzae. J Mol Biol. 1999 Mar 26;287(2):211–219. doi: 10.1006/jmbi.1999.2623. [DOI] [PubMed] [Google Scholar]
- Kuzmic P. Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase. Anal Biochem. 1996 Jun 1;237(2):260–273. doi: 10.1006/abio.1996.0238. [DOI] [PubMed] [Google Scholar]
- Li Yue, Gong Yunchen, Shi Genbin, Blaszczyk Jaroslaw, Ji Xinhua, Yan Honggao. Chemical transformation is not rate-limiting in the reaction catalyzed by Escherichia coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase. Biochemistry. 2002 Jul 9;41(27):8777–8783. doi: 10.1021/bi025968h. [DOI] [PubMed] [Google Scholar]
- Li Yue, Wu Yan, Blaszczyk Jaroslaw, Ji Xinhua, Yan Honggao. Catalytic roles of arginine residues 82 and 92 of Escherichia coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: site-directed mutagenesis and biochemical studies. Biochemistry. 2003 Feb 18;42(6):1581–1588. doi: 10.1021/bi026800z. [DOI] [PubMed] [Google Scholar]
- Shi G., Gao J., Yan H. 1H, 13C and 15N resonance assignments of Escherichia coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase and its complex with MgAMPPCP. J Biomol NMR. 1999 Jun;14(2):189–190. doi: 10.1023/a:1008309801414. [DOI] [PubMed] [Google Scholar]
- Stammers D. K., Achari A., Somers D. O., Bryant P. K., Rosemond J., Scott D. L., Champness J. N. 2.0 A X-ray structure of the ternary complex of 7,8-dihydro-6-hydroxymethylpterinpyrophosphokinase from Escherichia coli with ATP and a substrate analogue. FEBS Lett. 1999 Jul 30;456(1):49–53. doi: 10.1016/s0014-5793(99)00860-1. [DOI] [PubMed] [Google Scholar]
- Xiao B., Shi G., Chen X., Yan H., Ji X. Crystal structure of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase, a potential target for the development of novel antimicrobial agents. Structure. 1999 May;7(5):489–496. doi: 10.1016/s0969-2126(99)80065-3. [DOI] [PubMed] [Google Scholar]
- Xiao B., Shi G., Gao J., Blaszczyk J., Liu Q., Ji X., Yan H. Unusual conformational changes in 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase as revealed by X-ray crystallography and NMR. J Biol Chem. 2001 Aug 23;276(43):40274–40281. doi: 10.1074/jbc.M103837200. [DOI] [PubMed] [Google Scholar]
- Yan H., Blaszczyk J., Xiao B., Shi G., Ji X. Structure and dynamics of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase. J Mol Graph Model. 2001;19(1):70–77. doi: 10.1016/s1093-3263(00)00135-2. [DOI] [PubMed] [Google Scholar]